Igor Roshkovan alleged he started taking Sprycel in July 2019, a month after his leukemia was diagnosed. He sued the drugmaker in the US District Court for the Central District of California, alleging it failed to warn doctors and patients about this risk.
- Federal drug labeling law preempts Roshkovan’s claims, the court said Tuesday
- He didn’t sufficiently allege the existence of new information, not previously submitted to the Food and Drug Administration, that would have let ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.